Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
schizophrenia drug
Special Reports
Top 10 most anticipated drug launches of 2024
Every year, we tap Evaluate’s annual preview report to assess the biggest potential new drugs of the year ahead, but there are surprises on 2024's list.
Ben Adams
,
Nick Paul Taylor
Jan 29, 2024 6:00am
BMS sees ‘multi-billion-dollar opportunity’ in new Karuna drug
Jan 9, 2024 11:32am
AbbVie to tap Vraylar messaging lessons for Cerevel drug
Dec 8, 2023 6:07am
Teva taps Royalty to bankroll long-acting schizophrenia drug
Nov 13, 2023 11:40am
Gilead-backed Lyndra lays off staff as it nears pivotal data
Sep 15, 2023 3:33pm
New Alkermes ad wants Lybalvi to help patients 'push back'
Jun 7, 2023 9:20am